Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.47 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.44 |
| ▸ | IGF1R | P08069 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30444743 | 0.89 | TAAR1 (0.59) | TAAR1SIGMAR1IGF1RALOX15MAOA | |
| SCHEMBL16203114 | 0.89 | TAAR1 (0.59) | TAAR1SIGMAR1IGF1RALOX15MAOA | |
| SCHEMBL28585404 | 0.89 | TAAR1 (0.59) | TAAR1SIGMAR1IGF1RALOX15MAOA | |
| SCHEMBL13569139 | 0.87 | TAAR1 (0.61) | TAAR1SIGMAR1IGF1RALOX15MAOA | |
| SCHEMBL29618101 | 0.87 | SIGMAR1 (0.52) | SIGMAR1IGF1RALOX15MAOAMAPT | |
| SCHEMBL27390155 | 0.86 | LPL (0.51) | TAAR1 | |
| SCHEMBL5139428 | 0.83 | TAAR1 (0.61) | TAAR1SIGMAR1IGF1RALOX15MAOA | |
| SCHEMBL19524669 | 0.82 | TAAR1 (0.65) | TAAR1SIGMAR1SMN1; SMN2MAOB | |
| SCHEMBL22227406 | 0.80 | HTR7 (0.42) | SIGMAR1IGF1RALOX15 | |
| SCHEMBL23759726 | 0.80 | TDP2 (0.41) | SIGMAR1MAPTNPC1DAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116390928-A | Organic electroluminescent element, organic EL display device, and organic EL illumination | 三菱化学株式会社 | 2023-07-04 | — | — | CN | disclosed |
| WO-2022092046-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING | 三菱ケミカル株式会社 | 2022-05-05 | — | — | WO | disclosed |
| WO-2021161974-A1 | IRIDIUM COMPLEX COMPOUND, IRIDIUM COMPLEX COMPOUND-CONTAINING COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND PRODUCTION METHOD THEREFOR, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING DEVICE | 三菱ケミカル株式会社 | 2021-08-19 | — | — | WO | disclosed |
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| US-11038126-B2 | Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-06-15 | — | — | US | disclosed |
| US-20200274078-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | RB1, ARL1, CDKL1 | TAAR1 2276/4885SIGMAR1 4278/4885GABRG2 4470/4885 |
| US-11038126-B2 | Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device | ACVRL1, CCNL2, CXCR1 | TAAR1 829/4885SIGMAR1 956/4885GABRG2 3811/4885 |
| US-20200274078-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | ACVRL1, CCNL2, CXCR1 | TAAR1 829/4885SIGMAR1 956/4885GABRG2 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.